| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks
|
Uras, Iris Z.
|
|
|
133 |
15 |
p. 1677-1690
|
artikel
|
| 2 |
Characterization and treatment of congenital thrombotic thrombocytopenic purpura
|
Alwan, Ferras
|
|
|
133 |
15 |
p. 1644-1651
|
artikel
|
| 3 |
Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition
|
Eckstein, Olive S.
|
|
|
133 |
15 |
p. 1691-1694
|
artikel
|
| 4 |
Congenital TTP: toward a turning point
|
George, James N.
|
|
|
133 |
15 |
p. 1615-1617
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
133 |
15 |
p. i
|
artikel
|
| 6 |
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
|
Hay, Kevin A.
|
|
|
133 |
15 |
p. 1652-1663
|
artikel
|
| 7 |
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
|
Heavican, Tayla B.
|
|
|
133 |
15 |
p. 1664-1676
|
artikel
|
| 8 |
Immune dysregulation: EBV+ DLBCL and HLH in a patient with T-LGL
|
Zhan, Yougen
|
|
|
133 |
15 |
p. 1695
|
artikel
|
| 9 |
I myelofibrosis! Veni VitD! Et tu, macrophage?
|
Ng, Ashley P.
|
|
|
133 |
15 |
p. 1613-1615
|
artikel
|
| 10 |
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|
Sanz, Miguel A.
|
|
|
133 |
15 |
p. 1630-1643
|
artikel
|
| 11 |
Running the tank to empty: how far can the CAR go?
|
Vasu, Sumithira
|
|
|
133 |
15 |
p. 1617-1618
|
artikel
|
| 12 |
Vitamin D receptor–mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis
|
Wakahashi, Kanako
|
|
|
133 |
15 |
p. 1619-1629
|
artikel
|
| 13 |
When nucleated RBCs “count” in the peripheral blood: a unique case of post–essential thrombocythemia myelofibrosis
|
Thompson, Misty
|
|
|
133 |
15 |
p. 1696
|
artikel
|
Tijdschrift beschrijving